Carol Sherman to Adenocarcinoma
This is a "connection" page, showing publications Carol Sherman has written about Adenocarcinoma.
Connection Strength
0.019
-
Toxicity, response rates and survival outcomes of induction cisplatin and irinotecan followed by concurrent cisplatin, irinotecan and radiotherapy for locally advanced esophageal cancer. Jpn J Clin Oncol. 2011 Mar; 41(3):334-42.
Score: 0.019